Cytokinetics To Present Phase IIa Clinical Trials Data On Omecamtiv Mecarbil At The European Society Of Cardiology Congress 2009
Links shared publicly online about this topic.
- 1,797total visits
Cytokinetics To Present Phase IIa Clinical Trials Data On Omecamtiv Mecarbil At The European Society Of Cardiology Congress 2009
Cytokinetics, incorporated (nasdaq: cytk) announced that data relating to two phase iia clinical trials evaluating omecamtiv mecarbil (formerly ck-1827452), one in stable heart failure patients an
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Heart Failure, Clinical Trial, Cardiology
Most Recently Shared on August 25, 2009 at 1:28 pm By:
MedicalNewsToday: Cytokinetics To Present Phase IIa Clinical Trials Data On Omecamtiv Mecarbil http://bit.ly/7ewXA Full http://bit.ly/OYWwF
Advertisement
